Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Shabanowitz

Showing results (191-200 of 201) with videos related to

Pageof 21
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2012
Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targetsJoshua F Alfaro, Cheng-Xin Gong, Matthew E Monroe, et al.
Molecular & Cellular Proteomics : MCP|July 19, 2024
Are Internal Fragments Observable in Electron Based Top-Down Mass Spectrometry?Neven N Mikawy, Carolina Rojas Ramírez, Steven A DeFiglia, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 2, 2012
Trk activation of the ERK1/2 kinase pathway stimulates intermediate chain phosphorylation and recruits cytoplasmic dynein to signaling endosomes for retrograde axonal transportDavid J Mitchell, Kiev R Blasier, Erin D Jeffery, et al.
Iscience|September 10, 2021
Independent transcriptomic and proteomic regulation by type I and II protein arginine methyltransferasesMaxim I Maron, Stephanie M Lehman, Sitaram Gayatri, et al.
Cells|May 14, 2020
Deciphering the Enigma of the Histone H2A.Z-1/H2A.Z-2 Isoforms: Novel Insights and Remaining QuestionsManjinder S Cheema, Katrina V Good, Bohyun Kim, et al.
Scientific Reports|August 19, 2017
Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk allelesRebecca Pavlos, Elizabeth J McKinnon, David A Ostrov, et al.
Journal for Immunotherapy of Cancer|May 10, 2020
MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanomaVictor H Engelhard, Rebecca C Obeng, Kara L Cummings, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2012
Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoireDavid A Ostrov, Barry J Grant, Yuri A Pompeu, et al.
Cancers|October 23, 2021
Reinspection of a Clinical Proteomics Tumor Analysis Consortium (CPTAC) Dataset with Cloud Computing Reveals Abundant Post-Translational Modifications and Protein Sequence VariantsAmol Prakash, Lorne Taylor, Manu Varkey, et al.
Science Translational Medicine|September 20, 2013
MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemiaMark Cobbold, Hugo De La Peña, Andrew Norris, et al.
Pageof 21

Showing results (191-200 of 201) with videos related to

Sort By:
Pageof 21
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2012
Tandem mass spectrometry identifies many mouse brain O-GlcNAcylated proteins including EGF domain-specific O-GlcNAc transferase targetsJoshua F Alfaro, Cheng-Xin Gong, Matthew E Monroe, et al.
Molecular & Cellular Proteomics : MCP|July 19, 2024
Are Internal Fragments Observable in Electron Based Top-Down Mass Spectrometry?Neven N Mikawy, Carolina Rojas Ramírez, Steven A DeFiglia, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 2, 2012
Trk activation of the ERK1/2 kinase pathway stimulates intermediate chain phosphorylation and recruits cytoplasmic dynein to signaling endosomes for retrograde axonal transportDavid J Mitchell, Kiev R Blasier, Erin D Jeffery, et al.
Iscience|September 10, 2021
Independent transcriptomic and proteomic regulation by type I and II protein arginine methyltransferasesMaxim I Maron, Stephanie M Lehman, Sitaram Gayatri, et al.
Cells|May 14, 2020
Deciphering the Enigma of the Histone H2A.Z-1/H2A.Z-2 Isoforms: Novel Insights and Remaining QuestionsManjinder S Cheema, Katrina V Good, Bohyun Kim, et al.
Scientific Reports|August 19, 2017
Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk allelesRebecca Pavlos, Elizabeth J McKinnon, David A Ostrov, et al.
Journal for Immunotherapy of Cancer|May 10, 2020
MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanomaVictor H Engelhard, Rebecca C Obeng, Kara L Cummings, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2012
Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoireDavid A Ostrov, Barry J Grant, Yuri A Pompeu, et al.
Cancers|October 23, 2021
Reinspection of a Clinical Proteomics Tumor Analysis Consortium (CPTAC) Dataset with Cloud Computing Reveals Abundant Post-Translational Modifications and Protein Sequence VariantsAmol Prakash, Lorne Taylor, Manu Varkey, et al.
Science Translational Medicine|September 20, 2013
MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemiaMark Cobbold, Hugo De La Peña, Andrew Norris, et al.
Pageof 21